‌

US Patent 8586713 Readily isolated bispecific antibodies with native immunoglobulin format

Patent 8586713 was granted and assigned to Regeneron Pharmaceuticals, Inc. on November, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 19, 2013

Patent Application Number

12823838

Date Filed

June 25, 2010

Patent Citations Received

US Patent 12134633 Separation matrix

0

US Patent 12091460 Use of bispecific antigen-binding molecules that bind MUC16 and CD3 in combination with 4-1BB co-stimulation

0

US Patent 12103960 VEGF traps and mini-traps and methods for treating ocular disorders and cancer

0

US Patent 12129288 Polynucleotides heterodimers of soluble interferon receptors and uses thereof

0

US Patent 11655291 Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or activin A

0

US Patent 11660340 Combination therapy using T cell redirection antigen binding molecule against cell having immunosuppressing function

0

US Patent 11667671 Separation method

0

US Patent 11685764 Separation matrix

0

...

Patent Primary Examiner

Laura B Goddard

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8586713 Readily isolated bispecific antibodies with native immunoglobulin format

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool